Basic and Clinical Pharmacology 14th
Edition - Original Practice Test Bank
Chapters {1-66) ISBN: 9781259641169
Latest 2025/2026.
,
,1. Introduction: The Nature of Drugs & Drug Development & Regulation
Q1. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: A
patient on new drug application presents with characteristic adverse effect. What is the best
management?
A) Continue drug and reassure
B) Stop drug / give specific antidote / dose adjust per guidelines
C) Add another drug same class
, D) Switch to herbal alternative
Correct Answer: B) Stop drug / give specific antidote / dose adjust per guidelines
Explanation: Toxicities in 1. Introduction: The Nature of Drugs & Drug Development & Regulation
are target-related and require dose adjustment, discontinuation, or specific antidote; continuing
worsens outcome.
Q2. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: Which
clinical use is FDA-approved for phase 3 trial?
A) Indication covered in 1. Introduction: The Nature of Drugs & Drug Development &
Regulation
B) Unrelated dermatologic use
C) No approved use
D) Only veterinary use
Correct Answer: A) Indication covered in 1. Introduction: The Nature of Drugs & Drug
Development & Regulation
Explanation: phase 3 trial is prototypical for this chapter's indication; other uses are off-label or
incorrect.
Q3. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: A
patient on new drug application presents with characteristic adverse effect. What is the best
management?
A) Continue drug and reassure
B) Stop drug / give specific antidote / dose adjust per guidelines
C) Add another drug same class
D) Switch to herbal alternative
Correct Answer: B) Stop drug / give specific antidote / dose adjust per guidelines
Explanation: Toxicities in 1. Introduction: The Nature of Drugs & Drug Development & Regulation
are target-related and require dose adjustment, discontinuation, or specific antidote; continuing
worsens outcome.
Q4. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: A
patient on new drug application presents with characteristic adverse effect. What is the best
management?
A) Continue drug and reassure
B) Stop drug / give specific antidote / dose adjust per guidelines
C) Add another drug same class
Edition - Original Practice Test Bank
Chapters {1-66) ISBN: 9781259641169
Latest 2025/2026.
,
,1. Introduction: The Nature of Drugs & Drug Development & Regulation
Q1. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: A
patient on new drug application presents with characteristic adverse effect. What is the best
management?
A) Continue drug and reassure
B) Stop drug / give specific antidote / dose adjust per guidelines
C) Add another drug same class
, D) Switch to herbal alternative
Correct Answer: B) Stop drug / give specific antidote / dose adjust per guidelines
Explanation: Toxicities in 1. Introduction: The Nature of Drugs & Drug Development & Regulation
are target-related and require dose adjustment, discontinuation, or specific antidote; continuing
worsens outcome.
Q2. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: Which
clinical use is FDA-approved for phase 3 trial?
A) Indication covered in 1. Introduction: The Nature of Drugs & Drug Development &
Regulation
B) Unrelated dermatologic use
C) No approved use
D) Only veterinary use
Correct Answer: A) Indication covered in 1. Introduction: The Nature of Drugs & Drug
Development & Regulation
Explanation: phase 3 trial is prototypical for this chapter's indication; other uses are off-label or
incorrect.
Q3. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: A
patient on new drug application presents with characteristic adverse effect. What is the best
management?
A) Continue drug and reassure
B) Stop drug / give specific antidote / dose adjust per guidelines
C) Add another drug same class
D) Switch to herbal alternative
Correct Answer: B) Stop drug / give specific antidote / dose adjust per guidelines
Explanation: Toxicities in 1. Introduction: The Nature of Drugs & Drug Development & Regulation
are target-related and require dose adjustment, discontinuation, or specific antidote; continuing
worsens outcome.
Q4. Chapter 1 - Introduction: The Nature of Drugs & Drug Development & Regulation: A
patient on new drug application presents with characteristic adverse effect. What is the best
management?
A) Continue drug and reassure
B) Stop drug / give specific antidote / dose adjust per guidelines
C) Add another drug same class
